Copper Binding Peptide
Active Substance: GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex)
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (50 mg/vial)
Form: Lyophilized Powder
Laboratory Tested: View Lab Result
πΊπΈ USA Domestic:Β 2β7 Days Delivery
π International:Β 5β20 Days Delivery
GHK-Cu 50 mg by Dragon Pharma is a high-dose copper peptide studied for its potential role in tissue repair, collagen support, skin quality, and recovery-focused protocols. GHK-Cu is one of the most recognized regenerative peptides in peptide research and is widely discussed in connection with wound-healing support, connective tissue maintenance, and healthy-aging applications.
For athletes, bodybuilders, and highly active users, recovery is not only about muscle soreness. Connective tissue integrity, skin health, inflammation control, and repair capacity all influence long-term performance. For users looking to buy GHK-Cu 50 mg by Dragon Pharma, product quality, sterile handling, and reliable sourcing are essential.
GHK-Cu is a copper-binding tripeptide made from glycine, histidine, and lysine. It forms a stable complex with copper ions, which are involved in many biologic processes related to regeneration, collagen formation, antioxidant defense, and tissue remodeling.
This peptide occurs naturally in the human body, but levels decline with age. Because of that decline, GHK-Cu has become an important subject in research related to tissue maintenance, visible skin quality, and age-related repair capacity. The 50 mg format offers a larger supply for extended protocols or repeated use.
In performance-focused settings, GHK-Cu is often researched for its broad regenerative profile and its potential role in supporting the tissues that absorb repeated physical stress over time. It is commonly discussed in protocols centered on recovery, aesthetics, and structural support.
For a broader look at the peptide's regenerative research profile, you can refer to this PubMed review on GHK-Cu and tissue repair.
GHK-Cu has been studied in connection with tissue remodeling, collagen production, anti-inflammatory signaling, and wound-healing support. Research interest also extends into skin rejuvenation, hair-related studies, and broader gene-expression pathways associated with recovery and regeneration.
This wide research profile explains why GHK-Cu remains one of the better-known peptides in both cosmetic and athletic recovery discussions. For high-output users, the peptide is often explored as part of protocols focused on maintaining tissue quality and repair capacity over time.
Note: GHK-Cu is intended for research purposes only. The following reflects common protocol patterns and your provided context rather than medical advice.
GHK-Cu may be researched through subcutaneous or topical protocols depending on the intended application. Common research-oriented examples include:
The 50 mg vial is commonly reconstituted with 2 mL of bacteriostatic water, creating a concentration of 25 mg/mL. At that concentration, a 2 mg dose equals 0.08 mL, or 8 units on a U-100 insulin syringe. A 5 mg dose equals 0.2 mL, and a 10 mg dose equals 0.4 mL.
Female research protocols often use similar or slightly lower ranges depending on the intended goal. For skin-focused and cosmetic protocols, lower daily amounts or topical use are common. For broader regenerative research, many users begin conservatively and adjust only if needed.
GHK-Cu has a relatively short circulating half-life, but its research interest comes from downstream effects related to tissue remodeling, repair signaling, and cumulative use over time. This is why daily or repeated protocol use is commonly discussed in peptide communities.
GHK-Cu is generally discussed as well tolerated in research settings. When side effects are mentioned, they are usually mild and may include temporary injection-site irritation, brief skin flushing, a metallic taste, or topical irritation in localized skin applications.
Because this is a copper-binding peptide, users often pay attention to total protocol design and avoid unnecessarily aggressive dosing.
GHK-Cu should not be used by pregnant or nursing women. Individuals with copper metabolism disorders or serious chronic conditions should use caution when considering copper-based peptide protocols. Proper sterile handling and storage practices should always be followed. Keep out of reach of children.
Excessive use is unlikely to improve results and may increase the chance of irritation or unwanted copper-related effects. If accidental excessive use occurs, discontinue the protocol and seek medical advice.
GHK-Cu is often researched alongside other peptides connected to tissue repair, regeneration, and recovery support. Common combinations include:
These combinations are typically explored by users interested in connective tissue support, skin quality, recovery capacity, and longer-term regenerative maintenance.
Dragon Pharma presents GHK-Cu in a sterile 2 mL vial containing 50 mg of lyophilized powder. The freeze-dried format helps preserve stability before reconstitution and supports accurate dose preparation. The higher-dose vial is especially useful for extended protocols or repeated use over time.
Store the lyophilized vial in a cool, dry place away from direct light and moisture, ideally at 2-8Β°C. After reconstitution with bacteriostatic water, keep refrigerated and use within 2-3 weeks for best stability. Do not freeze.
This product is intended for laboratory research and analytical purposes only. Not for human consumption. Always verify the legality of this compound in your jurisdiction before purchase.
Dragon Pharma is committed to transparency and quality. Below are the latest third-party lab test results for GHK-Cu 50 mg, verifying purity and accurate dosing.
Lab test conducted: 2025-11-10 | Result: 55.10 mg (110.2% of labeled dose)
GHK-Cu is a research copper peptide studied for tissue repair, collagen support, skin quality, recovery, and regenerative applications. It is commonly explored in protocols involving connective tissue, wound-healing support, and healthy-aging research.
GHK-Cu binds copper and is studied for its potential influence on repair signaling, collagen-related activity, antioxidant balance, and gene-expression pathways connected to regeneration. This broad research profile is one reason it remains popular in tissue-support discussions.
Yes, GHK-Cu has gained interest among athletes, bodybuilders, and fitness-focused users because it is often researched for connective tissue support, recovery, skin quality, and long-term maintenance of tissues exposed to repeated physical stress.
To reconstitute the 50 mg vial, researchers commonly add 2 mL of bacteriostatic water and gently swirl until fully dissolved. This yields a concentration of 25 mg/mL for measured dosing during recovery or regenerative protocols.
To help verify authenticity, buy only from trusted sources that maintain proper storage conditions and provide clear product labeling. This product page also includes third-party lab results for Dragon Pharma GHK-Cu 50 mg showing a recent tested content result.
Please log in to write GHK-Cu 50 mg review.
Healing & Regenerative Peptide
Active Substance: Pentadecapeptide BPC 157
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Form: Lyophilized Powder
Laboratory Tested: View Lab Result
πΊπΈ USA Domestic:Β 2β7 Days Delivery
π International:Β 5β20 Days Delivery
Human Peptide Hormone
Active Substances:
- Thymosin Beta 4 5 mg
Β - Pentadecapeptide 5mg
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (10 mg/vial)
Laboratory Tested: View Lab Result